The human menopausal gonadotropin (hMG) dose in in vitro fertilization (IVF): What is the optimal dose?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Genetics(clinical),Developmental Biology,Obstetrics and Gynaecology,Genetics,Reproductive Medicine,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/BF02212923.pdf
Reference13 articles.
1. Ben Rafael Z, Benadiva CA, Ausmanas M, Barber B, Blasco L, Flickinger GL, Mastroianni LJ: Dose of human menopausal gonadotropin influences the outcome of an in vitro fertilization program. Fertil Steril 1987;48:964–968
2. Ben Rafael Z, Lipitz S, Bider D, Mashiach S: Ovarian hyporesponsiveness in combined gonadotropin-releasing hormone agonist and menotropin therapy is associated with low serum follicle-stimulating hormone levels. Fertil Steril 1991; 55:272–275
3. Blankstein J, Collins RL, Easley KA, Quigley MM: Increased human menopausal gonadotropin dose during the early follicular phase: Effect on follicular recruitment and treatment outcome. J Vitro Fert Embryo Transfer 1989;6:112–117
4. Hershlag A, Asis MC, Diamond MP, DeCherney AH, Lavy G: The predictive value and the management of cycles with low initial estradiol levels. Fertil Steril 1990;53:1064–1067
5. van Hooff MH, Alberda AT, Huisman GJ, Zeilmaker GH, Leerentveld RA: Doubling the human menopausal gonadotrophin dose in the course of an in-vitro fertilization treatment cycle in low responders: A randomized study. Hum Reprod 1993;8:369–373
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The association of serum estradiol level with outcomes of clomiphene citrate/human menopausal gonadotropin ovarian stimulation for in vitro fertilization and embryo transfer;Reproductive Biology and Endocrinology;2015-10-06
2. Increasing the Stimulation Dose of rFSH in Unexpected Poor Responders Is Not Associated with Better IVF Outcome;The Scientific World Journal;2012
3. Risk charts to identify low and excessive responders among first-cycle IVF/ICSI standard patients;Reproductive BioMedicine Online;2011-01
4. Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation;Human Reproduction Update;2007-11-15
5. Increasing the daily dose of recombinant follicle stimulating hormone (Puregon®) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation;Human Reproduction;2000-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3